Laughter Therapy

Effect and efficacy of Laughter Therapy (LT) in people with central nervous system disorders.

Description

The EvergreenHealth Multiple Sclerosis Center is conducting a prospective investigation of the effects of Laughter Therapy (LT) on perceived stress, self-efficacy, mood, and other wellness measures in people with the following neurological conditions: Multiple Sclerosis, Parkinson’s disease, Alzheimer’s disease, amyotrophic lateral sclerosis, Huntington’s disease, Post-Stroke, Brain Injury, and Spinal Cord Injury.

Currently enrolling
Who may be eligible to participate?
What does participation involve?
Investigator: Theodore Brown, M.D.

Patients older than 18 years old with a confirmed diagnosis of a neurological condition. Patients must be on a stable regimen of medication taken specifically to treat the given condition and be without any severe abdominal, chest, or back pain.

Participants will fill out questionnaires about their health before, during, and after attending a laughter therapy course. The course will take 1 hour, once a week for 8 weeks. The laughter therapy course will be led by a certified laughter therapy instructor. Participants will be responsible for completing questionnaires.

For More Information: Jana Akture – 425.899.5393, CAkture@evergreenhealth.com